Back
AVLN

AVLN

NASDAQ

Avalyn Pharma Inc. Common Stock

29.49

11.49(63.83%)
Volume

6.3M

Market Cap

$1.09B

P/E Ratio

-

EPS

-

Price Chart

Price Alerts

No price alerts set. Add an alert to get notified!

Notify when price goes above $120.00
Notify when price goes above $180.00
Notify when price goes below $180.00

Key Financial Ratios

P/E Ratio

-

P/B Ratio

-

EPS

-

ROE

-

Profit Margin

-

Operating Margin

-

Peer Comparison

Compare TSM with similar companies in the sector

Company Price Change % P/E Market Cap D/E

* Peer stocks are selected based on market capitalization and sector

Private Notes

Key Statistics

52 Week High

$30.20

52 Week Low

$26.00

Dividend

-

Dividend Yield

-

About Avalyn Pharma Inc. Common Stock

Avalyn Pharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). The company was founded by Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar on May 27, 2011 and is headquartered in Boston, MA.